Several common medicines — from heart drugs and antifungals to antipsychotics and HIV therapies — can shift the balance between androgens and estrogens in male breast tissue, triggering glandular growth. Understanding what causes gynecomastia helps put medication-related cases in context, since drug use is among the most common causes of non-physiologic gynecomastia.
Not every man who takes these medicines develops gynecomastia, and enlargement often has more than one cause at the same time. This post covers the medicine groups named in medical literature, what to discuss with the prescribing doctor, and when a surgical assessment becomes the appropriate next step.
How a Medicine Can Lead to Breast Enlargement
Male breast tissue stays flat because androgens (primarily testosterone) suppress its growth while estrogens stimulate it. When a medicine shifts this balance, the tissue can respond by growing [1].
Three ways a medicine can tip the balance
Evidence names the following mechanisms [2]:
- Antiandrogenic effect — the medicine blocks or weakens the androgen signal at breast tissue, so the estrogen signal goes unchallenged. Spironolactone, cimetidine, and ketoconazole work this way [2].
- Estrogenic effect — the medicine carries estrogen-like activity itself, or raises the amount of estrogen the body produces. Digoxin, anabolic steroids, and gonadotropin-releasing hormone agonists fall into this group [2].
- Increased metabolism of androgens — alcohol speeds up the breakdown of androgens, leaving relatively more estrogen activity behind [2].
- Raised sex hormone–binding globulin (SHBG) — diazepam and phenytoin can raise SHBG, which binds free testosterone and reduces the androgen effect on tissue [2].
- Hyperprolactinaemia — medicines such as haloperidol, metoclopramide, and phenothiazines raise prolactin, which indirectly disrupts the estrogen-to-androgen ratio [2].
Hormone balance
Male breast tissue stays flat because androgens (primarily testosterone) suppress its growth while estrogens stimulate it. When a medicine shifts this balance, the tissue can respond by growing [1].
Unknown mechanism
A separate group of medicines — including several antihypertensives, antidepressants, and antiretroviral agents — is consistently linked to gynecomastia in clinical reports, but the exact mechanism has not been established by evidence [2].
In practice
Any process that raises bioavailable estrogens, lowers free testosterone, or impairs androgen receptor responsiveness can trigger glandular growth in the male breast [1].
When the mechanism is not known
A separate group of medicines — including several antihypertensives, antidepressants, and antiretroviral agents — is consistently linked to gynecomastia in clinical reports, but the exact mechanism has not been established by evidence [2].
What this means in practice
Any process that raises bioavailable estrogens, lowers free testosterone, or impairs androgen receptor responsiveness can trigger glandular growth in the male breast [1].
Medicine Groups Linked to Gynecomastia
Several medicine groups appear in the medical literature as contributors to male breast enlargement. The table below covers only the groups named in the evidence. Strength of association is stated only as the evidence states it.
Key points
- Several medicine groups appear in the medical literature as contributors to male breast enlargement.
- Where a contributing agent is identified, stopping or switching it often allows breast tissue to regress.
- Antiandrogen treatment for prostate cancer, such as bicalutamide, is a well-documented cause of bilateral breast enlargement.
| Medicine group | Named examples | How strong is the link |
|---|---|---|
| Antiandrogens / prostate cancer therapies | Bicalutamide | High; long-term use is a common contributor [2, 3] |
| Mineralocorticoid receptor antagonists | Spironolactone (Aldactone) | High propensity; other agents in the same class, such as eplerenone (Inspra), have not produced similar effects [2] |
| Antipsychotics | Not individually named in the evidence | Named as a common contributor with long-term use [2] |
| Antiretrovirals (HIV medicines) | Highly active antiretroviral therapy (HAART) | Named as a common contributor with long-term use [2, 4] |
| Heart medicines | ACE inhibitors, calcium channel blockers | Linked to gynecomastia [4] |
| Stomach-acid / ulcer medicines | Not individually named in the evidence | Named as a medicine category linked to gynecomastia [5] |
| Antifungal medicines | Ketoconazole | Listed among agents commonly associated with gynecomastia [2] |
| Anti-anxiety medicines | Diazepam (Valium) | Can sometimes cause gynecomastia [4] |
| Opioids | Methadone, morphine | Noted to have hormonal side effects [4] |
| Anabolic steroids | — | Can cause gynecomastia; this group is covered in detail in a separate post on steroids. |
What this means in practice
Medication use and substance use are among the most common causes of non-physiologic gynecomastia after persistent pubertal gynecomastia [2]. Where a contributing agent is identified, stopping or switching it often allows breast tissue to regress [2, 3]. Before any surgery is considered, identifying and addressing a drug-induced cause is an important step [1].
A note on individual cases
A link seen in studies does not prove that a medicine caused enlargement in any one person. Many men take these medicines without developing gynecomastia, and enlargement can have more than one cause at the same time. A clinical assessment is needed to weigh each person’s situation.
Prostate cancer therapies
Antiandrogen treatment for prostate cancer, such as bicalutamide, is a well-documented cause of bilateral breast enlargement [3]. In those cases, watchful waiting, a change in prostate cancer treatment, or medical management with an agent such as tamoxifen may be discussed with the treating urologist [3]. Radiotherapy has also been considered for gynecomastia associated with antiandrogen therapy [3].
Timing, Medical History and Association Versus Cause
Why the Timeline Matters
When a man notices breast enlargement, one of the first questions a doctor asks is whether the swelling began after a medicine was started or after the dose was changed. This sequence does not prove that the medicine is responsible, but it is an important clue. If the condition stems from a medication, switching to a different drug may be enough to resolve it, and if the individual is using the medication for a short time, the condition will be temporary [6].
Other Causes Are Still Investigated
Even when the timing looks convincing, other explanations must still be checked. Nonphysiologic gynecomastia can occur at any age as a result of a number of medical conditions, medication use, or substance use [2]. Puberty, weight changes, and conditions affecting the liver, kidney, thyroid, or testes can all produce similar enlargement, and some of these may be present at the same time as a suspect medicine.
Dr. Purohit’s note: In Jaipur, Dr. Vishal Purohit begins assessment with clinical examination and direct palpation, then arranges ultrasound or MRI when imaging is needed, and requests hormone blood tests only when there are other symptoms of hormonal imbalance.
Association Is Not the Same as Proven Cause
For many medicines that appear in medical literature, the link to gynaecomastia rests on individual case reports rather than controlled studies. A temporal association — enlargement appearing after a medicine was started — is a reasonable reason to review the prescription, but it does not confirm that the medicine is the sole or definite cause [2].
Never Stop a Prescribed Medicine on Your Own
The decision belongs to the prescribing doctor
Only the doctor who prescribed a medicine can decide whether it should be continued, reduced, switched to an alternative, or stopped. Stopping some medicines suddenly can be harmful, so a patient who notices breast enlargement should not stop a medicine without guidance.
The right step is to raise the concern at the next appointment, or sooner if the enlargement is rapid or painful.
What may happen after a clinician-directed change
When a doctor reviews the situation and directs a change, outcomes depend on how long the enlargement has been present [3]:
- Early, tender breast tissue that has developed recently may settle once the offending medicine is adjusted or replaced [3, 7].
- Long-standing, firm glandular tissue that has been present for many months is less likely to resolve on its own [1, 3].
Questions to Take to Your Doctor
What to Ask the Prescribing Clinician
Before stopping or changing any medicine, a man who notices chest enlargement should raise the following with the doctor who prescribed it:
- Could this medicine be contributing to the breast enlargement I am experiencing?
- Is there an alternative medicine that carries a lower risk of this effect?
- What changes in the chest should I watch for while continuing or switching treatment?
- After how long, and at what point, should the chest be re-examined to see whether the enlargement has settled?
When a Plastic Surgeon Becomes Relevant
These questions are worked through with the prescribing clinician first. If the enlargement persists even after the medicine has been stopped or changed and the underlying cause has been addressed, a consultation with a plastic surgeon is the appropriate next step, because glandular breast tissue that has been present for some time does not reliably resolve on its own [2].
When Enlargement Persists
When drug-induced gynecomastia has been present for a long time, the glandular tissue can become fibrous [1]. Fibrous tissue does not respond to stopping the offending medicine and is unlikely to shrink on its own [3]. At that stage, a surgical assessment becomes the logical next step [3].
Dr. Vishal Purohit’s approach to medicines
In Jaipur, Dr. Vishal Purohit does not prescribe medicines for gynecomastia. Once the gland is removed surgically, it cannot grow back, making medication unnecessary.
Persistent Drug-Induced Gynecomastia: Getting an Assessment in Jaipur
When gynecomastia has been present for a long time despite addressing the suspected medicine, glandular tissue can become fibrous and will not resolve on its own. At that point, a surgical consultation is the appropriate next step. To understand what the procedure involves, visit the gynecomastia surgery in Jaipur page, or explore common patient questions on the gynecomastia FAQs page. Dr. Vishal Purohit in Jaipur can be reached by WhatsApp at +91 7718183535.
This is educational information, not medical advice.
